enGene to Participate in Upcoming Investor Conferences
Financial Post · Business Wire ·
BOSTON & MONTREAL -- enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today
BOSTON & MONTREAL — enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor conferences:
UBS Global Biopharma Conference 2026
Date: Monday, November 16, 2026
Read the full story at Financial Post · All coverage of this story